5R tumor cells were not available, and C-type virus-infected fibroblasts, macrophages, and lymphocytes of adult mice are relatively bad targets and stimulator cells for the FMR system. All the experiments with 5R cells were therefore set up with lipopolysaccharide (LPS) blasts of adult mice infected when newborn with MLV, as described recently (V. Duprez, Y. H~nin, and J. P. L~vy. Manuscript in preparation.). Such blast cells behave in serological and ceilmediated reactions like FMR lymphoma cells; they are, however, less sensitive to immune cytolysis.
Immune Lymphocytes. Immune spleen cells from mice inoculated intramuscularly with MSV were taken 10-15 d after inoculation for primary chromium release tests (CRT), and 3-30 wk later for in vitro restimulation by syngeneic FMR(+) cells. Restimulation was performed as previously described (2) .
CRT. The CRT was performed as previously described (2) in microtiter plates (Titertek; Flow Laboratories, Paris), with each well receiving 104 SlCr-labeled target cells and normal or immune lymphocytes so that the effector:target cell ratio varied from 100:1 to 3:1. The chromium release was measured after 18 h of incubation in primary and 4 h of incubation in secondary reactions.
Competition Experiments. The competition experiments were performed by adding increasing amounts of unlabeled competitor cells to the CRT mixture as described previously (2) .
Blocking by Anti-H-2 Sera.
Blocking by anti-H-2 sera was performed with cells previously incubated for 20 min at 4°C with 1/2 diluted sera as targets for the CRT (3). The sera were obtained by repeated inoculations of allogenic spleen cells in recipient adult mice. Three different sera were used: anti-H-2b: (BALB/c × C3H/He)F1 anti-BALB.B; anti-H-2Db: (B10.RIII × B10.Br)F~ anti-B10.A(4R); and anti-H-2Kb: B10.A anti-B10.A(5R). Table I shows the results of a typical experiment involving in vivo primed anti-MSV T killer cells and H-2 b or H-2 a lymphoma target cells. It appears, as described previously (3) , that MBL2 (H-2 b) was killed only by CTL sharing the D b specificity, and LSTRA (H-2 d) only by attacker lymphocytes sharing d specificities at the K end of the major histocompatibility complex (MHC). On the other hand, HTI and 5R 
Results
* Effector cells have been taken from the spleen of MSV-infected mice 10-15 d after infection of 0.1 ml of 1:100 diluted MSV. :~ Percent chromium release from target cells with effector:target cell ratio of 100:1 and after an 18-h incubation period. The mean standard errors being always between 0.4 and 2% are not given. In all cases, the activity of immune CTL was calculated by comparison with the activity of normal lymphoid cells of the same inbred strains. Practically no differences were found in the level of activity of the different normal lymphocytes. The lack of detectable reactivity of in vivo primed 5R lymphocytes against H-2K h + FMR or H-2D d + FMR could be a result of the weakness of such reactions. Secondary stimulations were therefore necessary to test this point. As mentioned in Materials and Methods, 5R lymphoma cells bearing the FMR antigen were not available. LPS blast cells of 5R mice infected with MLV at the time of birth were therefore used following a recently developed method (V. Duprez, H. H~nin, and J. P. Lfivy. Manuscript in preparation.). Table II (Table IV) .
The ability to react or not react with K b 4-FMR is thus genetically determined; B6 and B10 mice being nonresponder in contrast to 5R mice. Table V The relative unsensitivity of the method used to detect virion-associated H-2 antigens could explain that a lesser but significant amount of K b molecules might have been missed in the virions. A specific cocapping of H-2D b and FMR molecules has also been reported (11, 12) , although not confirmed in other experiments with the same or other methodologies (2, 13) . Quantitative problems or the use of different cells perhaps explain this discrepancy. Furthermore, the cocapping phenomenon might be unrelated to the CTL-reacting structure of the cell surface that is directly explored by the present experiments.
There exists an obvious hierarchy of FMR + H-2 antigenic associations, and (16, 17) . In terms of altered self, the receptor for D b 4-FMR could be more efficient that any other. In terms of dual recognition, it could be imagined that CTL that bear an H-2D b self receptor would be able to develop an antigen receptor specific for FMRof higher affinity than the precursors that bear a receptor for H-2K b or H-2D a self. The results observed in the FMR system might be especially interesting, because they suggest that the antigenic association chosen for the response is the one providing the higher level of protection: mice that respond against O b 4-FMR regularly produce a good level of CTL after primary immunization, and they possess memory cells at least 8 mo later. In contrast, 5R mice that are obliged to respond against a weaker antigenic association (i.e., K b 4-FMR) produce CTL activity after secondary stimulation only. Furthermore, memory cells disappear early in this case. (5R X B10)Fa hybrids are low responders against K b 4-FMR, responsiveness against this association being recessive, but they produce a primary anti-FMR response associated to D b, like the high-responder B10 patient, the high level of antiviral responses is therefore dominant.
The apparent discrepancy existing between the usual dominant responsiveness at Ir genes of the antibody responses and the dominant unresponsiveness against certain H-2 + viral antigens (i.e., K b + FMR) for K or D region-associated CTL that control genes (Results [4] ) is probably a result of the double subsets of precursors that exist in the latter case even in homozygous mice. As a matter of fact, CTL precursors can respond against the antigen associated to either H-2D or H-2K. The situation is similar to that of an F1 hybrid between responder and nonresponder parents in the antibody response. In this case, F1 hybrids respond preferentially with the antigen associated to Ia of the responder parent (18, 19) . Ir genes that control CTL or antibody responses, therefore, are both characterized by (a) dominant high-responder phenotype and (b) the choice of the best possible MHC product + antigen association, explaining unresponsiveness against certain associations and permitting dominance of the higher response. They seem to differ only by their mapping to different regions of the H-2 complex. 
